Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 28;15(7):1647.
doi: 10.3390/nu15071647.

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

Affiliations
Review

Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms

Claudia Di Rosa et al. Nutrients. .

Abstract

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain associated with defecation or a change in bowel habits. The pathogenesis of IBS is not completely clear, but it is known to be multifactorial and complex. Endogenous and exogenous factors such as abnormal GI motility, low-grade inflammation, increased epithelial permeability and visceral hypersensitivity, but diet and psychosocial aspects are also recognized as important actors. Furthermore, the interaction between diet and gut microbiota has gained interest as a potential contributor to the pathophysiology of IBS. To date, there is no specific diet for IBS with constipation (IBS-C); however, many studies show that fiber intake, especially soluble fiber such as inulin, could have a positive effect on symptoms. This review aims to evaluate the effects of some nutritional components such as fibers but also functional foods, prebiotics, probiotics and symbiotics on symptoms and microbiota in IBS-C subjects.

Keywords: IBS and diet; IBS and microbiota; irritable bowel syndrome and diet; irritable bowel syndrome with constipation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

Cited by

References

    1. Drossman D.A. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016;150:1262–1279.e2. doi: 10.1053/j.gastro.2016.02.032. - DOI - PubMed
    1. Lacy B.E., Mearin F., Chang L., Lembo J.A., Simren M., Spiller R., Chey D.W. Bowel disorders. Gastroenterology. 2016;150:1393–1407. doi: 10.1053/j.gastro.2016.02.031. - DOI - PubMed
    1. Kindt S., Louis H., De Schepper H., Arts J., Caenepeel P., De Looze D., Gerkens A., Holvoet T., Latour P., Mahler T., et al. Belgian consensus on irritable bowel syndrome. Acta Gastroenterol. Belg. 2022;85:360–382. doi: 10.51821/85.2.10100. - DOI - PubMed
    1. Chey W.D., Kurlander J., Eswaran S. Irritable bowel syndrome: A clinical review. J. Am. Med. Assoc. 2015;313:949–958. doi: 10.1001/jama.2015.0954. - DOI - PubMed
    1. Sperber A.D., Bangdiwala S.I., Drossman D.A., Ghoshal U.C., Simren M., Tack J., Whitehead W.E., Dumitrascu D.L., Fang X., Fukudo S., et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160:99–114. doi: 10.1053/j.gastro.2020.04.014. - DOI - PubMed

LinkOut - more resources